ALNY
E446844
ALNY is the stock ticker symbol for Alnylam Pharmaceuticals, a biotechnology company specializing in RNA interference (RNAi) therapeutics.
All labels observed (1)
| Label | Occurrences |
|---|---|
| ALNY canonical | 1 |
How this entity was disambiguated
This entity first appeared as the object of triple T4492406 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: ALNY Context triple: [Alnylam Pharmaceuticals, tickerSymbol, ALNY]
-
A.
AL
AL is the common abbreviation for the American League, one of the two major professional baseball leagues that make up Major League Baseball in the United States and Canada.
-
B.
AL
AL is the official postal abbreviation for the Brazilian state of Alagoas, located in the country's Northeast region.
-
C.
AL
AL is the two-letter ISO 3166 country code representing the Republic of Albania.
-
D.
Alnôba
Alnôba is an Indigenous Algonquian language traditionally spoken by the Western Abenaki people of northeastern North America.
-
E.
Alloway
Alloway is a village in South Ayrshire, Scotland, best known as the birthplace of the poet Robert Burns.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: ALNY Target entity description: ALNY is the stock ticker symbol for Alnylam Pharmaceuticals, a biotechnology company specializing in RNA interference (RNAi) therapeutics.
-
A.
AL
AL is the common abbreviation for the American League, one of the two major professional baseball leagues that make up Major League Baseball in the United States and Canada.
-
B.
AL
AL is the official postal abbreviation for the Brazilian state of Alagoas, located in the country's Northeast region.
-
C.
AL
AL is the two-letter ISO 3166 country code representing the Republic of Albania.
-
D.
Alnôba
Alnôba is an Indigenous Algonquian language traditionally spoken by the Western Abenaki people of northeastern North America.
-
E.
Alloway
Alloway is a village in South Ayrshire, Scotland, best known as the birthplace of the poet Robert Burns.
- F. None of above. chosen
Statements (48)
| Predicate | Object |
|---|---|
| instanceOf |
biotechnology company
ⓘ
public company ⓘ stock ticker symbol ⓘ |
| collaboratesWith |
Novartis
NERFINISHED
ⓘ
Regeneron Pharmaceuticals NERFINISHED ⓘ Sanofi (historical collaboration) NERFINISHED ⓘ |
| country |
United States of America
ⓘ
surface form:
United States
|
| develops |
AMVUTTRA (vutrisiran)
NERFINISHED
ⓘ
GIVLAARI (givosiran) NERFINISHED ⓘ ONPATTRO (patisiran) NERFINISHED ⓘ OXLUMO (lumasiran) NERFINISHED ⓘ |
| employs | scientists specializing in RNA interference ⓘ |
| focusesOn |
RNAi-based drugs
ⓘ
genetic medicines ⓘ |
| foundedBy |
David Bartel
NERFINISHED
ⓘ
David R. Corey NERFINISHED ⓘ John Maraganore NERFINISHED ⓘ Other co-founders associated with RNAi field ⓘ Paul Schimmel NERFINISHED ⓘ Phil Zamore NERFINISHED ⓘ Phillip A. Sharp NERFINISHED ⓘ Thomas Tuschl NERFINISHED ⓘ |
| foundedIn | 2002 ⓘ |
| hasAbbreviation | Alnylam NERFINISHED ⓘ |
| hasCUSIP | 02043Q107 ⓘ |
| hasISIN | US02043Q1076 ⓘ |
| hasKeyPerson |
John Maraganore
NERFINISHED
ⓘ
Yvonne Greenstreet NERFINISHED ⓘ |
| hasModality | gene silencing ⓘ |
| hasPipeline | RNAi therapeutics in clinical development ⓘ |
| hasTherapeuticArea |
cardiometabolic diseases
ⓘ
central nervous system diseases ⓘ hepatic infectious diseases ⓘ rare diseases ⓘ |
| headquartersLocation | Cambridge, Massachusetts, United States NERFINISHED ⓘ |
| industry | biotechnology ⓘ |
| languageOfWork | English ⓘ |
| listedOn | NASDAQ ⓘ |
| regulatoryRegion | United States Food and Drug Administration jurisdiction ⓘ |
| represents | Alnylam Pharmaceuticals, Inc. NERFINISHED ⓘ |
| specializesIn |
RNA interference therapeutics
ⓘ
RNAi therapeutics ⓘ |
| targets | mRNA for degradation via RNAi ⓘ |
| technology | RNA interference ⓘ |
| tickerSymbol | ALNY NERFINISHED ⓘ |
| tradedAs | NASDAQ:ALNY NERFINISHED ⓘ |
| usesDeliveryPlatform |
GalNAc conjugate delivery
ⓘ
lipid nanoparticle delivery ⓘ |
How these facts were elicited
The pipeline generated the facts above by prompting gpt-5.1 with this entity's name + description and the instruction below.
Instruction
You are a knowledge base construction expert. Given a subject entity and a description of it, return factual statements that you know for the subject as a JSON list of dictionaries(triples), where keys must be "subject", "predicate" and "object". The number of facts may be very high, between 25 to 50 or more, for very popular subjects. For less popular subjects, the number of facts can be very low, like 5 or 10. # Requirements - If you don't know the subject at all, return an empty list. - If the subject is not a named entity, return an empty list. - Include at least one triple where predicate is "instanceOf". - Do not get too wordy. - Separate several objects into multiple triples with one object.
Input
Subject: ALNY Description of subject: ALNY is the stock ticker symbol for Alnylam Pharmaceuticals, a biotechnology company specializing in RNA interference (RNAi) therapeutics.
Referenced by (1)
Full triples — surface form annotated when it differs from this entity's canonical label.